Apadaz™ (benzhydrocodone/acetaminophen) – New drug approval
February 23, 2018 - KemPharm announced the FDA approval of Apadaz (benzhydrocodone/acetaminophen [APAP]) for the short-term (no more than 14 days) management of acute pain severe enough to require an opioid analgesic and for which alternative treatments are inadequate.
Top